Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide (ACCESS)
Recruiting
18 years - 65 years
All
Phase
N/A
180 participants needed
1 Location
Brief description of study
This is a prospective, multi-center, Phase II study of hematopoietic cell transplantation using human leukocyte antigen-mismatched unrelated donors for peripheral blood stem cell transplant in adults and bone marrow stem cell transplant in children.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Blood Transplant Marrow TransplantLeukemiaLymphoma
-
Age: 18 years - 65 years
-
Gender: All
Age 1-66 Diagnosis of Leukemia
Updated on
20 Feb 2025.
Study ID: 849440